Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda Cirincione

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|September 22, 2016
Population pharmacokinetics of exenatideBrenda Cirincione, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics|September 27, 2017
The American Conference on Pharmacometrics 2017 (ACoP8)Brenda Cirincione, Navin Goyal, Rene Bruno
The AAPS Journal|November 30, 2016
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose AdministrationBrenda Cirincione, Jeffrey Edwards, Donald E Mager
Journal of Clinical Pharmacology|May 26, 2017
Influence of Meals and Glycemic Changes on QT Interval DynamicsBrenda Cirincione, Philip T Sager, Donald E Mager
Journal of Clinical Pharmacology|May 26, 2017
Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV InfusionBrenda Cirincione, Frank LaCreta, Philip Sager, et al.
The AAPS Journal|October 12, 2012
Study reanalysis using a mechanism-based pharmacokinetic/pharmacodynamic model of pramlintide in subjects with type 1 diabetesJing Fang, Cornelia B Landersdorfer, Brenda Cirincione, et al.
Pharmacoepidemiology and Drug Safety|April 27, 2017
The renal elimination of apixaban: the totality of data relating to the renal clearance of apixaban in patients with impaired renal function: response to Hellfritzsch et alWonkyung Byon, Brenda Cirincione, Gregory Di Russo, et al.
Journal of Clinical Pharmacology|June 25, 2009
Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patientsSadahiro Abe, Koji Chiba, Brenda Cirincione, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Population Pharmacokinetics Analysis To Inform Efavirenz Dosing Recommendations in Pediatric HIV Patients Aged 3 Months to 3 YearsMan Luo, Sunny Chapel, Heather Sevinsky, et al.
The AAPS Journal|April 6, 2007
Informatics: the fuel for pharmacometric analysisThaddeus H Grasela, Jill Fiedler-Kelly, Brenda Cirincione, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|September 22, 2016
Population pharmacokinetics of exenatideBrenda Cirincione, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics|September 27, 2017
The American Conference on Pharmacometrics 2017 (ACoP8)Brenda Cirincione, Navin Goyal, Rene Bruno
The AAPS Journal|November 30, 2016
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose AdministrationBrenda Cirincione, Jeffrey Edwards, Donald E Mager
Journal of Clinical Pharmacology|May 26, 2017
Influence of Meals and Glycemic Changes on QT Interval DynamicsBrenda Cirincione, Philip T Sager, Donald E Mager
Journal of Clinical Pharmacology|May 26, 2017
Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV InfusionBrenda Cirincione, Frank LaCreta, Philip Sager, et al.
The AAPS Journal|October 12, 2012
Study reanalysis using a mechanism-based pharmacokinetic/pharmacodynamic model of pramlintide in subjects with type 1 diabetesJing Fang, Cornelia B Landersdorfer, Brenda Cirincione, et al.
Pharmacoepidemiology and Drug Safety|April 27, 2017
The renal elimination of apixaban: the totality of data relating to the renal clearance of apixaban in patients with impaired renal function: response to Hellfritzsch et alWonkyung Byon, Brenda Cirincione, Gregory Di Russo, et al.
Journal of Clinical Pharmacology|June 25, 2009
Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patientsSadahiro Abe, Koji Chiba, Brenda Cirincione, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Population Pharmacokinetics Analysis To Inform Efavirenz Dosing Recommendations in Pediatric HIV Patients Aged 3 Months to 3 YearsMan Luo, Sunny Chapel, Heather Sevinsky, et al.
The AAPS Journal|April 6, 2007
Informatics: the fuel for pharmacometric analysisThaddeus H Grasela, Jill Fiedler-Kelly, Brenda Cirincione, et al.
Pageof 2